These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2217510)
1. Effects of Mel B arsobal and alpha-difluoromethylornithine on the awakening electroencephalogram of humans with gambiense trypanosomiasis disease: preliminary report. Hamon JF; Seri B; Doua F; Camara P; Aba L Pharmacol Biochem Behav; 1990 Aug; 36(4):831-5. PubMed ID: 2217510 [TBL] [Abstract][Full Text] [Related]
2. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)]. Hamon JF; Camara P Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798 [TBL] [Abstract][Full Text] [Related]
3. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Bales JD; Harrison SM; Mbwabi DL; Schecter PJ Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816 [TBL] [Abstract][Full Text] [Related]
4. [Trypanosomal meningo-encephalitis observed in France. Reflections concerning the use of arsobal]. Siguier F; Betourne C; Lanza M; Herreman G; Piette F Bull Mem Soc Med Hop Paris; 1967 May; 118(8):717-22. PubMed ID: 6060517 [No Abstract] [Full Text] [Related]
5. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis]. Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492 [TBL] [Abstract][Full Text] [Related]
6. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system. Jennings FW Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647 [TBL] [Abstract][Full Text] [Related]
7. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo]. Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863 [TBL] [Abstract][Full Text] [Related]
9. [EEG and treatment with Arsobal in human African trypanosomiasis]. Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245 [TBL] [Abstract][Full Text] [Related]
10. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire. Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607 [TBL] [Abstract][Full Text] [Related]
11. The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal. APTED FI Trans R Soc Trop Med Hyg; 1953 Sep; 47(5):387-98. PubMed ID: 13102579 [No Abstract] [Full Text] [Related]
12. The therapeutic effect on a group of sleeping sickness patients of a single injection of 3854 R.P. (mel B Friedheim-arsobal Spécia). PINTO AR Am J Trop Med Hyg; 1954 May; 3(3):464-5. PubMed ID: 13158766 [No Abstract] [Full Text] [Related]
13. [Electroencephalographic study of meningoencephalitis from Trypanosoma gambiense before and after treatment with melarsoprol]. Hamon JF; Camara P Neurophysiol Clin; 1991 Aug; 21(3):173-81. PubMed ID: 1944068 [TBL] [Abstract][Full Text] [Related]
14. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. Taelman H; Schechter PJ; Marcelis L; Sonnet J; Kazyumba G; Dasnoy J; Haegele KD; Sjoerdsma A; Wery M Am J Med; 1987 Mar; 82(3 Spec No):607-14. PubMed ID: 3103442 [TBL] [Abstract][Full Text] [Related]
15. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)]. Sina GC; Triolo N; Cramet B; Suh Bandu M Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902 [TBL] [Abstract][Full Text] [Related]
16. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome]. Pialoux G; Kernbaum S; Vachon F Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients]. Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491 [TBL] [Abstract][Full Text] [Related]
18. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense]. Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607 [TBL] [Abstract][Full Text] [Related]
19. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225 [TBL] [Abstract][Full Text] [Related]